Picture of Alk-Abello A/S logo

ALK B — Alk-Abello A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: ALK-Abello's Regulatory Filing For Allergy Tablet Is Accepted For Review In China

Feb 3 (Reuters) - ALK-Abello A/S  ALKb.CO :
    * REGULATORY FILING FOR HOUSE DUST MITE ALLERGY TABLET
ACCEPTED
FOR REVIEW IN CHINA
    * CHINESE REGULATORY REVIEW PROCESS IS ANTICIPATED TO
COMPLETE IN
2024 SO THAT, SUBJECT TO APPROVAL, WIDER MARKET INTRODUCTION
COULD FOLLOW SHORTLY HEREAFTER

Source text for Eikon:  ID:nGNE5dxFmd 
Further company coverage:  ALKb.CO 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Alk-Abello A/S

See all news